Brian E McGeeney
Affiliation: Boston University
- Cannabinoids and hallucinogens for headacheBrian E McGeeney
Boston University School of Medicine, Boston, MA 02118, USA
Headache 53:447-58. 2013..The legal status of cannabinoids and hallucinogens has for a long time severely inhibited medical research, and there are still no blinded studies on headache subjects, from which we could assess true efficacy...
- Hallucinogens and cannabinoids for headacheBrian E McGeeney
Department of Neurology, Boston Medical Center and Boston University, Boston, MA 02118, USA
Headache 52:94-7. 2012..Hallucinogens are being increasing used by cluster headache patients outside of physician recommendation mainly to abort a cluster period and to maintain quiescence for which there is considerable anecdotal success...
- Topiramate in the treatment of cluster headacheBrian E McGeeney
Pain Management Group, Department of Neurology, Boston University School of Medicine, 715 Albany Street, C329, Boston, MA 02118, USA
Curr Pain Headache Rep 7:135-8. 2003..This article provides an overview of topiramate and the open-label studies of this agent in the prevention of cluster headache...
- Cluster headache pharmacotherapyBrian E McGeeney
Department of Neurology, Boston University School of Medicine, Boston, Massachusetts 02118, USA
Am J Ther 12:351-8. 2005..Most procedures are directed against the sensory trigeminal nerve and associated ganglia, eg, anesthetizing the sphenopalatine ganglion...
- Valsalva-induced cluster headacheBrian E McGeeney
Department of Neurology, Boston University School of Medicine, Boston, MA, USA
J Headache Pain 7:416-8. 2006..Attacks occurred a couple of times a week in the patient presented, solely triggered by valsalva manoeuvres including coughing, sneezing or straining and not by exercising...
- Adjuvant agents in cancer painBrian E McGeeney
Pain Management Group, Department of Neurology, Boston University School of Medicine, Boston, MA 02118, USA
Clin J Pain 24:S14-20. 2008..Potentially harmful treatments are considered, as well as the numbers needed to treat, mechanisms of action, and clinical trial data for agents that can be beneficial for the management of cancer-associated neuropathic pain...
- Pharmacological management of neuropathic pain in older adults: an update on peripherally and centrally acting agentsBrian E McGeeney
Pain Management Group, Neurology Department, C329, Boston University School of Medicine, 72 East Concord Street, Boston, MA 02118, USA
J Pain Symptom Manage 38:S15-27. 2009..The health care professional should have a thorough familiarity with all medications available to treat this difficult group of disorders...